Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
12:29pm, Wednesday, 26'th Jun 2024
Ginkgo Bioworks (NYSE: DNA ) layoffs continue today with the cell programming company announcing additional job cuts. The latest update to the Ginkgo Bioworks layoffs reveals that the company is plann
Why Ginkgo Bioworks Stock Is Sinking Today
11:19am, Wednesday, 26'th Jun 2024
Ginkgo Bioworks continued its slide from earlier in the week. The company is cutting 25% of its workforce.
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
10:31am, Monday, 24'th Jun 2024
Ginkgo Bioworks (NYSE: DNA ) layoffs are coming for 158 of the company's employees and more are on the way. Ginkgo Bioworks has revealed that it's going to be cutting 158 jobs as part of its effort to
Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research
08:50am, Monday, 24'th Jun 2024
CORALVILLE, Iowa--(BUSINESS WIRE)-- #Amplicon--Advancing virology research: IDT's xGen™ HIV Amplicon Panel consisting of primers designed to cover 99.3% of the HIV genome is now available.
5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains
12:31pm, Thursday, 20'th Jun 2024
Investing in penny stocks can reward bold, patient investors. But patience can be in short supply when you can just buy NVIDIA (NASDAQ: NVDA ) and sleep well at night.
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability - - Applied DNA Secures Commercial Linea RNAP Quantity Suff
7 Penny Stocks to Sell in June Before They Crash & Burn
12:00pm, Wednesday, 19'th Jun 2024
The stock market continues to climb. But in this case, a rising tide isn't necessarily lifting all boats.
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
09:00am, Tuesday, 18'th Jun 2024
Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic (PGx) Test STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (N
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
08:00am, Monday, 17'th Jun 2024
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a p
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
09:00am, Thursday, 13'th Jun 2024
STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York Stat
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
04:05pm, Tuesday, 11'th Jun 2024
35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases, sexually transmitted and urine tract infecti
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
05:10am, Tuesday, 11'th Jun 2024
The S&P 500 has hit more than one record high this year, and technology stocks have led the gains. It's a great idea to get in on stocks that have remained in the doldrums but could have a bright futu
Integrated DNA Technologies Announces New Primers and Probe Set to Identify H5N1 Avian Influenza
08:52am, Monday, 10'th Jun 2024
CORALVILLE, Iowa--(BUSINESS WIRE)-- #AvianFlu--A new PCR/qPCR solution from IDT will support surveillance and monitoring of the current H5N1 strain of bird flu.
After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)
10:36am, Friday, 07'th Jun 2024
Ginkgo Bioworks (DNA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in rev
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
09:00am, Wednesday, 05'th Jun 2024
Patent covers the Composition of the Company's Proprietary Linea™ RNAP, a Core Technology Empowering the Linea™ IVT Platform Patent Application Also Currently Pending in Key International Markets
